AstraZeneca launches virtual research laboratory
July 31, 2012Medical Communications Assay Depot, AstraZeneca, R&D, virtual
AstraZeneca and partner Assay Depot have launched a virtual research laboratory aimed at helping its scientists create R&D collaborations. The …
Soren Tulstrup to lead Shire’s genetics franchise
July 31, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Shire has appointed Soren Tulstrup as its new senior vice president and franchise lead, MPS (mucopolysaccharides) for its human genetic …
Bayer raises guidance after strong sales
July 31, 2012Sales and Marketing Bayer, Nexavar, Q2, Xarelto, Yasmin
The Bayer Group has raised its full-year guidance for 2012 following positive results in the second quarter. This is despite …
Fitch to pharma: don’t expect 2012 to be a bumper year
July 31, 2012Sales and Marketing 2012, FDA approvals, Fitch, IMS Health, NMEs, ratings
The Fitch ratings agency has published pessimistic projections for pharma, saying that it should not expect as many US drug …
Leading producer of auto injectors SHL hires over 600 new employees
July 31, 2012Manufacturing and Production auto injector, autoinjector, pen injector, shl group
In response to increased customer orders and the signing of long-term contracts, SHL has hired more than 600 new employees …
Merck sees growth in second quarter
July 30, 2012Sales and Marketing Cozaar, Merck, Q2, Singulair
Merck has posted a healthy sales increase for the second quarter, as its established drugs grew strongly. Sales increased 1% …
Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops
July 30, 2012Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss
A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …
Bayer guilty of multiple Code breaches
July 30, 2012Medical Communications, Sales and Marketing ABPI Code, Bayer, Xarelto, breach, clause
Bayer Healthcare has admitted to 12 breaches of the ABPI Code after one of its staff developed and distributed drug …
Novartis’ David Meek moves to Endocyte
July 30, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Endocyte, Novartis, appointment
David Meek has been appointed to the newly created position of chief commercial officer at the biotechnology firm Endocyte. Meek …
immatics’ vaccine increases survival in kidney cancer
July 30, 2012Research and Development, Sales and Marketing IMA901, Vaccine, Yervoy, immatics, phase III
immatics’ investigational cancer vaccine has increased survival rates in patients with renal cell carcinoma. In a late-stage trial, the German …
J&J expects consent decree to extend through ‘most of 2013’
July 30, 2012Manufacturing and Production FDA, J&J, JJ, McNeil, OTC, recall
Johnson & Johnson has said it expects the production capacity issues affecting two plants covered by a consent decree with …
Prevenar 13 rejected for UK vaccination programme
July 27, 2012Sales and Marketing JCVI, Pfizer, Pneumovax, Sanofi Pasteur, prevenar 13
The UK’s joint committee on vaccination and immunisation is recommending against a switch to Pfizer’s pneumococcal vaccine Prevenar 13 from …
IT problems at Swedish plant affect AstraZeneca
July 27, 2012Manufacturing and Production AstraZeneca, Nexium, Symbicort, financials
Software problems at a manufacturing facility operated by AstraZeneca in Sweden are having a material impact on the business, pegging …
Roche posts strong sales results
July 27, 2012Sales and Marketing Pegasys, Perjeta, Roche, Zelboraf, dalcetrapib
Roche has published healthy revenue growth for the first half of 2012, but its profits have taken a hit. The …
Acting chair of Public Health England appointed
July 26, 2012Sales and Marketing David Heymann, Public Health England
David Heymann has been appointed as the acting chair of Public Health England. Dr Heymann, currently chairman of the Health …
AstraZeneca’s Fluenz chosen for wider flu immunisation
July 26, 2012Sales and Marketing AZ, AstraZeneca, Cervarix, Gardasil, Lansley, MedImmune
The UK has chosen AstraZeneca’s Fluenz to extend the country’s flu vaccination programme. The health secretary Andrew Lansley said that …
AstraZeneca sees big sales drop in Q2
July 26, 2012Sales and Marketing AstraZeneca, Brennan, Brilinta, Q2, Seroquel
AstraZeneca has today reported a large drop in revenue for the second quarter. The firm has been hit by major …
Janssen launches drug reminder service ‘Care4Today’
July 26, 2012Medical Communications Care4Today, Janssen, digital
Janssen has launched a new digital service designed to help patients remember to take their medication. Care4Today Mobile Adherence is …
The fight over ‘Obamacare’ goes on
July 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Medicaid, Obama, Obamacare, Romney, US, healthcare
The recent ruling by the US Supreme Court which upheld President Obama’s healthcare reforms could save the country around $84 …
Life appoints senior copywriter
July 26, 2012Medical Communications Elinor Washbrook, Life
Life Healthcare Communications has appointed a new senior copywriter to develop its creative team. Elinor Washbrook joins Life with over …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
